International Journal of Pharma and Bio Sciences
 
 
    ISSN 0975-6299
www.ijpbs.net


ORIGINAL RESEARCH ARTICLE
Int J Pharm Bio Sci Volume 14 Issue 3, July-September 2023, Pages:1-5

Glycosylated Haemoglobin as A Marker of Severity in Patients with Acute Myocardial Infarction

Dr. Kumar Ujjwal, Dr. D. P. Lakra and Dr. M. Khande
DOI: http://dx.doi.org/10.22376/ijpbs.2023.14.3.p1-5
Abstract:

Hyperglycaemia is an independent risk factor for cardiovascular diseases (CVD). Glycosylated hemoglobin A1c (HbA1c) is a pivotal bio-marker reflecting fasting and postprandial plasma glucose concentration over the preceding 2–3 months. And also, it has been regarded as an important tool in diabetes diagnosis and management. The study evaluated the utility of HBA1c in determining the severity of Acute Myocardial Infarction in Tertiary Care Hospitals. The prospective analytical cross-sectional study was carried out among 169 patients aged 18 years and above admitted with Acute myocardial infarction at a tertiary care center from November 2021 to October 2022. The severity of MI was done using TIMI Score for STEMI/ NSTEMI. The collected data were analyzed with proper statistical methods using MS Excel 2016. Data were summarized in percentages and proportions. P value <0.05 was considered statistically significant. The mean age of the patients was 60.50 ±10.94 years, with the majority of cases being male. (63.91%) There was a strong association between the risk category and HbA1c with statistically significant differences. TIMI risk score had a strong positive correlation with HbA1c. (P<0.0001) The present study concludes a significant correlation between HbA1c levels and the severity of Acute Myocardial Infarction.

Keywords: Glycosylated Haemoglobin, Severity, Acute Myocardial Infarction, HbA1c, TIMI risk score
Full HTML:
  1. Alomari M, Bratton H, Musmar A, Al Momani LA, Young M. Ticagrelor-induced Diarrhea in a Patient with Acute Coronary Syndrome Requiring Percutaneous Coronary Artery Intervention. Cureus. 2019 Jan 12;11(1):e3874.
  2. Gilutz H, Shindel S, Shoham-Vardi I. Adherence to NSTEMI Guidelines in the Emergency Department: Regression to Reality. Crit Pathw Cardiol. 2019 Mar;18(1):40-46. 
  3. Zègre-Hemsey JK, Asafu-Adjei J, Fernandez A, Brice J. Characteristics of Prehospital Electrocardiogram Use in North Carolina Using a Novel Linkage of Emergency Medical Services and Emergency Department Data. Prehosp Emerg Care. 2019 Nov-Dec;23(6):772-779.
  4. Harris M, Zimmet P. Classification of diabetes mellitus and other categories of glucose intolerance. In: Alberti K, Zimmet P, De Fronzo R, editors. International Textbook of Diabetes Mellitus. Chichester: John Willey and Sons Ltd; 1997. pp. 9–23. 
  5. International Diabetes Federation 2011. The Global Burden Prevalence and Projections 2011 and 2030.
  6. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291–1297. 
  7. Deng D, Liu L, Xu G, Gan J, Shen Y, Shi Y, Zhu R, Lin Y. Epidemiology and Serum Metabolic Characteristics of Acute Myocardial Infarction Patients in Chest Pain Centers. Iran J Public Health. 2018 Jul;47(7):1017-1029.
  8. Bhalla MA, Khan MQ, Samore NA, Mehreen S. Frequency and clinical outcome in conduction defects in acute myocardial infarction. J Ayub Med Coll Abbottabad 2009;21:32-7.  
  9. Chandrashekar G, Pathi N. Conduction Blocks in Acute Myocardial Infarction: A Prospective Study. Int J Sci Stud 2016;4(6):1-6.
  10. Ram Ratan, Devi Konsam Biona, Chanu Keisham Jaya, Devi Th Shanti,     Naorem Santa, Chongtham Dhanaraj Singh.Study of conduction blocks in acute myocardial infarction. 2016;30:149-152.
  11. Kock HL, deBruin A, et al. Incidence of first acute myocardial infarction in the Netherlands. The Netherlands Journal of Medicine. 2007;65(11):434-441.
  12. Gosavi S, Karande S, Raut K. HbA1c: a marker for severity of acute myocardial infarction. Int. Arch. Integr. Med.. 2016;3:89-93.
  13. Emad Abu-Assi, José M. García-Acuña, Carlos Peña-Gil, and José R. González-Juanatey. Validation of the GRACE Risk Score for Predicting Death Within 6 Months of Follow-Up in a Contemporary Cohort of Patients With Acute Coronary Syndrome. Rev Esp Cardiol. 2010;63(6):640-8.
  14. Patel RS, Eshtehardi P, Dhawan S, McDaniel MC, Rab ST, Vaccarino V, Zafari AM, Samady H, Quyyumi AA. Coronary angiographic scoring systems: an evaluation of their equivalence and validity. Am Heart J. 2012 Oct;164(4):547-552.e1.
  15. de Araújo Gonçalves P, Ferreira J, Aguiar C, Seabra-Gomes R. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascularization in NSTE-ACS. Eur Heart J. 2005 May;26(9):865-72
  16. Avci A, Fidan S, Tabakç? MM, Toprak C, Alizade E, Acar E et al. Association between the Gensini Score and Carotid Artery Stenosis. Korean Circ J. 2016 Sep; 46(5):639-645.
  17. Neeland IJ, Patel RS, Eshtehardi P, Dhawan S, McDaniel MC, Rab ST, Vaccarino V, Zafari AM, Samady H, Quyyumi AA. Coronary angiographic scoring systems: an evaluation of their equivalence and validity. Am Heart J. 2012 Oct;164(4):547-552.e1.
  18. Cakar MA, Sahinkus S, Aydin E, Vatan MB, Keser N, Akdemir R, Gunduz H. Relation between the GRACE score and severity of atherosclerosis in acute coronary syndrome. J Cardiol. 2014 Jan;63(1):24-8
  19. Hong LF, Li XL, Guo YL, Luo SH, Zhu CG, Qing P, Xu RX, Wu NQ, Li JJ. Glycosylated hemoglobin A1c as a marker predicting the severity of coronary artery disease and early outcome in patients with stable angina. Lipids in health and disease. 2014 Dec;13(1):1-9.
  20. Scheen AJ. Cardiovascular effects of new oral glucose-lowering agents: DPP-4 and SGLT-2 inhibitors. Circ Res. (2018) 122:1439–59.
  21. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al.. Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - (2019). Executive Summary. Endocr Pract. (2019) 25:69–100.
[Download PDF]
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy
Pharmaceutical Fields
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmaceutics
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Novel drug delivery system
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Nanotechnology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacology
Welcome to IJPBS,Pharmaceutics, Novel, drug, delivery, system, Nanotechnology, Pharmacology, Pharmacognosy Pharmacognosy
© Copyright 2009-2015 IJPBS, India. All rights reserved. Specialized online journals by ubijournal. Website by Ubitech Solutions
         Home I Contact I Terms & Conditions